Insight Molecular Diagnostics Inc. (IMDX): Total Assets
$25.76M
As of 2025-12-31
$29.44M
As of 2026-06-30
-36.4%
3-year compound annual growth
-14.2%
5-year compound annual growth
+7.3%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $25.76M | -26.6% | 2026-03-26, Balance as of period end |
| 2024-12-31 | $35.08M | -53.2% | 2026-03-26, Balance as of period end |
| 2023-12-31 | $74.89M | -25.2% | 2025-03-24, Balance as of period end |
| 2022-12-31 | $100.09M | -37.3% | 2024-04-16, Balance as of period end |
| 2021-12-31 | $159.56M | +187.9% | 2023-04-12, Balance as of period end |
| 2020-12-31 | $55.42M | +39.0% | 2022-03-11, Balance as of period end |
| 2019-12-31 | $39.86M | +318.8% | 2021-03-19, Balance as of period end |
| 2018-12-31 | $9.52M | -6.8% | 2020-03-26, Balance as of period end |
| 2017-12-31 | $10.22M | -29.3% | 2019-04-01, Balance as of period end |
| 2016-12-31 | $14.45M | +13.5% | 2018-04-02, Balance as of period end |
| 2015-12-31 | $12.73M | n/a | 2017-02-27, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | 2025-12-31 | $25.76M | -26.6% |
| Biomerica Inc (BMRA) | 2026-05-31 | $6.76M | +13.7% |
| Anbio Biotechnology (NNNN) | 2025-12-31 | $30.24M | +59.8% |
| Aspira Women's Health Inc. (AWHL) | 2025-12-31 | $5.46M | -0.6% |
| Volitionrx Ltd (VNRX) | 2025-12-31 | $6.90M | -26.6% |
| Celldex Therapeutics, Inc. (CLDX) | 2025-12-31 | $582.98M | -26.4% |
| Immucell Corp (ICCC) | 2025-12-31 | $42.53M | -5.7% |
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | $103.58M | -12.8% |
| Intellia Therapeutics, Inc. (NTLA) | 2025-12-31 | $842.13M | -29.3% |
Compare IMDX, BMRA, NNNN, AWHL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗